People channel feed – Endpoints News

People channel feed

Art Krieg comes down from the mountain with a $27M round for Checkmate Pharmaceuticals

8 years ago

Little Aziyo is growing a new regenerative med company, led by some familiar faces in the biz

8 years ago

With Novartis and Google jumping in, Medicxi unveils a $300M late-stage biotech fund with a transatlantic scope

8 years ago

Alexion's Hantson poaches Biogen CFO Clancy as buzz of a looming pipeline shakeup heats up

8 years ago

Top JPMorgan investment banker brings his talents — and connections — to the biotech startup crew on board Flagship

8 years ago

Little Dragonfly bursts onto the I/O scene with a $33M Celgene deal and some of the biggest names in biotech

8 years ago

So what’s star Broad investigator Feng Zhang up to now?

8 years ago

Bristol-Myers vet Douglas Manion bids Big Pharma farewell, takes the helm at Yale spinout Kleo

8 years ago

J&J woos Merck's Mathai Mammen to helm of pharma R&D, Hait takes over on external innovation

8 years ago

Kelly Martin once again finds himself at the helm of a biotech, sailing in choppy seas

8 years ago

Christoph Westphal finds the exit at his latest biotech creation — after the stock cratered

8 years ago

Alexion’s new CEO is bringing an old colleague in to run R&D, can new deals be far behind?

8 years ago

Scientist-turned-VC: Kevin Bitterman takes his biotech hatching experience to a new role at Atlas

8 years ago

Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for

8 years ago

Constellation Pharma recruits its former BD chief to take the helm as CEO

8 years ago

Amgen vet Patrick Baeuerle inspires a $45M round from A-list VCs for a next-gen I/O drug platform

8 years ago

Ludwig Hantson is cleaning house at Alexion, booting R&D chief Martin Mackay and other execs

8 years ago

Trump administration doubles down on slashing the budget at NIH, FDA — with a user fee hike for biopharma

8 years ago

After a bruising turn as Sarepta CEO, Chris Garabedian is back in biotech with a new role as godfather to a bunch of startups

8 years ago

AstraZeneca throws a monkey wrench in new GSK CEO’s first hiring decision, suing Luke Miels

8 years ago

With major backing from New York and China, Athenex sets sights on a $100M cancer drug IPO

8 years ago

Biogen CSO Artavanis-Tsakonas heads back to Harvard, lab funding in hand

8 years ago

Genzyme founder, biotech entrepreneur and industry legend Henri Termeer dies

9 years ago

Glaxit: Flagging a looming threat from Gilead and a weak pipeline, Neil Woodford is giving up on GSK and pulling out

9 years ago

First page Previous page 94 95 969798 99 100 Next page Last page